Garvey LJ, Smith CJ, Stingone C, et al. Fall in HCV incidence in hiv+MSM in London following wider access to DAA therapy. CROI 2019, abstract 85.
Bezlotoxumab ter preventie van recidiverende 'Clostridium difficile'-infecties
nov 2018 | Bacteriële infecties